German pharmaceutical companies BioNTech and Pfizer have asked Europe to approve their coronavirus vaccines for emergency use.
Pfizer and BioNTech said that the submission, which occurred Monday, completes the rolling review process. (Photo: Reuters)
German pharmaceutical company BioNTech and its US partner Pfizer have asked for conditional approval for their coronavirus vaccines from the European Medicines Agency.
As per a report in Associated Press, the pharma firms say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency.
The two companies said on Tuesday that the submission, which occurred Monday, completes the rolling review process they initiated with the agency on October 6.
The move comes a day after rival Moderna said it was asking US and European regulators to allow emergency use of its Covid-19 vaccine.
As per the report, BioNTech said that if the vaccine, currently named BNT162b2, is approved, its use in Europe could begin before the end of 2020.
(With inputs from Associated Press)